MAPO Group

What MAPO Group does

MAPO Group a.s. is a privately held Czech healthcare conglomerate founded in 2015, with operational roots traceable to TRIVISION (2010) and structured as a public limited company (akciová společnost). The group operates a vertically integrated healthcare ecosystem spanning medical and pharmaceutical distribution, multi-specialty outpatient clinics, in-house pharmacies, home healthcare, hospital partnership, and professional medical education. MAPO employs more than 1,500 staff, including over 200 physicians, and serves over two million cumulative patients and more than 1,000 business partners through wholly-owned subsidiaries. The group's clinical footprint includes MAPO care clinics in Šumperk (2019), Prague (2022), and Olomouc (2024), plus a strategic partnership in Nemocnice Šumperk where approximately CZK 1.5 billion has been deployed over ten years under the leadership of Chairman JUDr. Martin Polach.

The group's operating brands include MAPO medical (medical supply distribution, certified disinfection programs, biomedical devices), MAPO pharma (pharmaceutical distribution), MAPO care (multi-specialty outpatient clinics offering proctology, orthopedics, rheumatology, dermatology, ORL, gastroenterology, allergology/immunology, and day surgery), MAPO lékárna (on-site pharmacies co-located with clinics), MAPO home care (home healthcare launched February 2024), MAPO academy (medical education platform with nearly 80 events over five semesters), MAPO revma (largest private rheumatology biologic treatment provider in the Czech Republic, based in Ostrava), and FERTIMED (IVF clinic integrated in 2018). The technology infrastructure relies on established medical practice management platforms — SmartMEDIX, Cygnus, and Medicus — rather than proprietary AI systems. A notable operational first is the 2021 deployment of the 'fleet care' surgical instrument management system at Nemocnice Šumperk, the first such implementation in Central and Eastern Europe.

MAPO Group generates revenue across four primary streams: (1) healthcare services through MAPO care clinics, billed primarily via contracts with all Czech public health insurers and supplemented by self-pay; (2) B2B distribution of medical materials and pharmaceuticals through MAPO medical and MAPO pharma, supported by a logistics center in Brno (opened 2019); (3) home healthcare services funded by health insurance reimbursements and out-of-pocket payments; and (4) pharmacy retail through MAPO lékárna. In 2023, the group reported revenue exceeding CZK 1.5 billion (~USD 60–65 million) for the first time. Distribution is conducted through direct B2B sales teams, owned clinics, owned pharmacies, and the home care field workforce; patients access care via self-referral or health insurance routing, with active hiring across 17 open roles supporting the growth plan.

Name

MAPO Group

Legal name

MAPO Group a.s.

Website

https://mapogroup.cz

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

51–100 employees

Short description

MAPO Group is a Czech private healthcare conglomerate operating an integrated ecosystem of medical and pharmaceutical distribution, multi-specialty outpatient clinics, on-site pharmacies, home healthcare, and medical education, serving over two million cumulative patients and 1,000 business partners across the Czech Republic.

Ownership category

akta.pro rank

Product category

Outpatient Healthcare Services

NAICS

Offices of Other Health Practitioners (6213), Offices of All Other Miscellaneous Health Practitioners (621399)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Hospital Shared Services, GPOs & System Support Organizations (HLAFAAAO)

Keywords

• Outpatient healthcare services
• Medical supply distribution
• Pharmaceutical distribution
• Home healthcare services
• Multi-specialty clinics

Headquarters

HQ city

Prostejov

HQ country

Czechia

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Healthcare Services (MAPO care clinics): MAPO Group operates outpatient clinics (MAPO care in Šumperk, Prague, Olomouc) offering multi-specialty care (proctology, orthopedics, rheumatology, dermatology, ORL, gastroenterology, day surgery). Revenue generated through health insurance reimbursements from all Czech health insurers and co-pays from patients. Care is predominantly covered by public health insurance.
2. Medical and Pharmaceutical Distribution (MAPO medical, MAPO pharma): Distribution of medical materials, health technologies, aids, certified disinfection programs, and biomedical devices to healthcare partners. MAPO medical operates a modern logistics center in Brno opened in 2019. Revenue generated through product sales and distribution fees to pharmacies, hospitals, and medical facilities.
3. Home Healthcare (MAPO home care): Home healthcare services provided in Šumperk and expanding to Olomouc/Prostějov regions. Services are prescribed by treating physicians and provided to long-term patients post-discharge. Revenue funded via health insurance reimbursements and self-paying patients.
4. Pharmacy Retail (MAPO lékárna): MAPO operates its own pharmacy at MAPO care Šumperk (the first MAPO pharmacy) and at the Olomouc clinic. Revenue generated through prescription fills (reimbursed by health insurers) and OTC/supp sales to patients.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

MAPO Group operates an integrated Czech healthcare ecosystem delivering multi-specialty outpatient medical care through MAPO care clinics (Šumperk, Prague, Olomouc), distributes medical supplies and pharmaceuticals to healthcare partners via MAPO medical and MAPO pharma, provides home healthcare services through MAPO home care, operates affiliated pharmacies (MAPO lékárna), runs a rheumatology center (MAPO revma) and an IVF clinic (FERTIMED), and delivers medical education via MAPO academy. Services are contracted with all Czech public health insurers and the group serves both B2C patients and B2B partners (pharmacies, hospitals, medical facilities).

Product overview

MAPO Group operates as an integrated healthcare ecosystem combining multiple sub-brands: MAPO care operates multi-specialty clinics in Šumperk, Praha, and Olomouc; MAPO medical handles medical supply distribution; MAPO pharma distributes pharmaceuticals; MAPO home care provides home healthcare services; MAPO lékárna operates affiliated pharmacies; and MAPO academy delivers professional education. The group also includes acquired brands FERTIMED (IVF clinic) and maintains a strategic partnership with Nemocnice Šumperk. With 1,500+ employees, 200+ doctors, and 2+ million treated patients, the portfolio spans from medical distribution to direct patient care.

Differentiator

Problem solved

Functional benefit

Brands

• MAPO medical: Distribution of medical devices, technologies, and supplies
• MAPO pharma
• MAPO home care
• MAPO care
• MAPO lékárna
• MAPO academy

Products and services

• MAPO care multi-specialty outpatient clinics Network of multi-specialty outpatient clinics in Šumperk, Prague, and Olomouc providing diagnostic, therapeutic, preventive, and day surgery services across multiple specialties, covered by contracts with all Czech public health insurers.
• MAPO medical B2B distribution of medical supplies, health technologies, aids, certified disinfection programs, and biomedical devices to pharmacies, hospitals, and medical facilities across the Czech Republic.
• MAPO pharma B2B pharmaceutical distribution services within the MAPO Group ecosystem, supplying partner pharmacies, hospitals, and medical facilities.
• MAPO home care Home healthcare services delivered directly to patients in the Šumperk district (with planned expansion to Olomouc and Prostějov). Services are physician-prescribed for post-discharge and long-term patients, and also available to self-paying clients.
• MAPO lékárna Retail pharmacies co-located at MAPO care clinics (Šumperk and Olomouc) providing prescription fulfillment, OTC medications, supplements, medical devices, and pharmaceutical consultations.
• MAPO academy Professional medical education platform organizing seminars, conferences, and symposia for medical professionals and the general public on the latest healthcare practices; nearly 80 events held over five semesters.
• MAPO revma Specialized rheumatology center located in Ostrava (Modrý pavilon), providing biologic treatment for rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis (Bechtěrevova nemoc).
• FERTIMED IVF clinic IVF and fertility treatment clinic integrated into MAPO Group in 2018, providing assisted reproduction services.

Quantifiable outcome

• CZK 1.5 billion+ revenue in 2023
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Nemocnice Šumperk (Šumperk Hospital)coreStrategic or Co-development Partner · 1 April 2015MAPO Group has partnered with Nemocnice Šumperk since 2015, investing nearly CZK 1.5 billion into its modernization and development over 10 years. Investments include new operating theaters, a radiodiagnostic pavilion with MRI, and renovation of long-term nursing care. The hospital serves 200,000+ regional residents. In 2024, Nemocnice Šumperk acquired Pavilion C which will undergo major reconstruction. The partnership represents MAPO's deepest strategic hospital alliance in Central and Eastern Europe.

Scale indicators7 records

Recent moves21 records

Expansion highlights5 records

Direct peers

• Medicover: Medicover operates a network of multi-specialty clinics, hospitals and diagnostic centers across Central and Eastern Europe (including the Czech Republic via Medicover). It shares MAPO's integrated clinic-and-diagnostics business model and is a key regional competitor for specialty outpatient care.
• AGEL: AGEL is one of the largest private hospital and clinic operators in the Czech Republic and Central Europe, providing inpatient, outpatient and pharmacy services. It competes directly with MAPO's hospital partnership model and multi-specialty clinic footprint across Czech regions.
• EUC (European Health Centres): EUC is the largest private healthcare network in the Czech Republic, operating multi-specialty outpatient clinics, hospitals and pharmacies. Like MAPO, it contracts with Czech health insurers and offers multi-specialty care under one roof — making it the closest direct competitor in the Czech private clinic market.
• Pharmos a.s. Pharmos is one of the leading Czech pharmaceutical wholesalers and distributors. As MAPO pharma is a pharma distribution business, Pharmos is a directly comparable B2B distribution competitor in the Czech market.
• Penta Hospitals: Penta Hospitals operates hospital and outpatient networks across Central Europe (Czech Republic, Slovakia, Poland). It is comparable to MAPO in operating multi-specialty outpatient services contracted with public health insurers and competing for regional referral flows.

Broad incumbents

• PHOENIX Group: PHOENIX Group is the largest pharmaceutical distributor in Europe, operating across more than 25 countries including the Czech Republic. It competes with MAPO pharma at the broader wholesale level but does not specialize in MAPO's combined clinic-and-distribution model.
• HARTMANN GROUP: HARTMANN is a European medical device and hygiene products manufacturer/distributor with operations including Central Europe. Comparable to MAPO medical in supplying healthcare facilities with medical materials, technologies and disinfection programs, but as a broader incumbent portfolio player.

Regional players

• MedLife: MedLife is the largest private healthcare network in Romania, operating multi-specialty clinics, hospitals and laboratories. It offers a directly comparable integrated outpatient clinic business model but operates in a different (Romanian) market from MAPO.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/mapogroup
• LinkedInlinkedin.com/company/mapo-group-a.s.

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MAPO Group